Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes
about
Molecular biology of breast cancer metastasis. The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer.Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma.Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trialsSignificance of ipsilateral breast tumor recurrence after breast conserving treatment: role of surgical removal.A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancerBlock sequential adriamycin CMF--optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer?DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy.New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes.Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomas.Novel Doxorubicin Derivatives: Synthesis and Cytotoxicity Study in 2D and 3D in Vitro Models.
P2860
Q24801047-29E143B4-070E-4045-A00C-30B0329BD91BQ31791116-42530B2F-A904-4191-9091-701C079D9E55Q36387794-2AD14EE8-8571-4EB8-89C9-D525FB57A715Q36563257-A4FC21B7-5A22-4C00-A843-95A56D852A22Q36617051-CBE26B91-AC83-46C3-A485-0C7E5587CB61Q36646508-D56AB557-CB8A-4075-9B68-9A7C687D8444Q37621452-DCECF6C0-6974-4D0E-92FA-D199D5D813E0Q41702637-30BCAE18-80E8-48E2-B5FA-60DE25979FB8Q44059739-98A4C75B-5E7A-4214-95F9-84F1518944E3Q49240708-CB4C1496-0630-4CFC-98D3-3B90B76D5610
P2860
Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes
description
1991 nî lūn-bûn
@nan
1991 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Adjuvant chemotherapy with dox ...... three positive axillary nodes
@ast
Adjuvant chemotherapy with dox ...... three positive axillary nodes
@en
Adjuvant chemotherapy with dox ...... three positive axillary nodes
@nl
type
label
Adjuvant chemotherapy with dox ...... three positive axillary nodes
@ast
Adjuvant chemotherapy with dox ...... three positive axillary nodes
@en
Adjuvant chemotherapy with dox ...... three positive axillary nodes
@nl
prefLabel
Adjuvant chemotherapy with dox ...... three positive axillary nodes
@ast
Adjuvant chemotherapy with dox ...... three positive axillary nodes
@en
Adjuvant chemotherapy with dox ...... three positive axillary nodes
@nl
P2093
P1476
Adjuvant chemotherapy with dox ...... three positive axillary nodes
@en
P2093
G Bonadonna
M Zambetti
P Valagussa
P304
P356
10.1200/JCO.1991.9.12.2134
P407
P577
1991-12-01T00:00:00Z